Laterality Spectrum Disorders in the Prenatal Era: Outcomes Across the Severity Spectrum and Associations with Pregestational Diabetes
American Journal of Perinatology · 2026-06 · 43 (08) · 1051-1058
DOI: 10.1055/a-2852-5042 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 24.04.2026. Verfasst von Kunio Tanaka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States. Hauptthemen laut MEDLINE: Pregnancy in Diabetics, Heart Defects, Congenital, Heterotaxy Syndrome.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
This study aimed to describe severity-stratified early outcomes in pregnancies with prenatally suspected laterality spectrum disorders (LSD), defined as abnormalities of left–right body patterning affecting thoracoabdominal situs and associated cardiovascular and visceral structures, and to explore phenotype patterns associated with pregestational diabetes mellitus (PDM). Study Design Retrospective cohort study of pregnancies evaluated at a tertiary fetal care and fetal cardiology referral center (2010–2026). LSD subtype was assigned using a prespecified operational framework. Cardiac severity was classified as major versus nonmajor congenital heart disease (CHD). Outcomes included termination, intrauterine fetal demise (IUFD), neonatal survival (≤28 days), infant survival (28 days–1 year), cardiac surgery, and gastrointestinal morbidity.
Results
Seventy-eight pregnancies were included; 16/78 (20.5%) had PDM. Major CHD was present in 49/78 (62.8%). Pregnancy outcomes included live birth in 62/78 (79.5%), IUFD in 5/78 (6.4%), and termination in 11/78 (14.1%); all terminations occurred among major CHD cases. Among live births, neonatal survival was 59/62 (95.2%), and infant survival among neonatal survivors was 46/53 (86.8%). In major CHD live births (n = 33), neonatal survival was 30/33 (90.9%) and infant survival among neonatal survivors with available follow-up was 20/27 (74.1%). Cardiac surgery occurred in 22/62 (35.5%) and was more common in major versus nonmajor CHD (63.6 vs. 3.4%). Intestinal malrotation occurred in 18/62 (29.0%). Abdominal situs inversus was more frequent in PDM pregnancies (37.5 vs. 8.1%).
Conclusion
In LSD, major CHD drives pregnancy termination, surgical intervention, and early mortality concentrated during infancy. PDM was associated with a higher frequency of abdominal situs phenotypes, supporting deliberate postnatal gastrointestinal surveillance planning. Key Points In LSD, infant outcomes vary with CHD severity. Major CHD drives termination/surgery. PDM occurs across the LSD spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, United States.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kunio Tanaka
Zitieren
APA
Tanaka, K., Seger, L., Tieu, K., Witcher, K., Turan, O., & Turan, S. (2026). Laterality Spectrum Disorders in the Prenatal Era: Outcomes Across the Severity Spectrum and Associations with Pregestational Diabetes. American Journal of Perinatology, 43(08), 1051-1058. https://doi.org/10.1055/a-2852-5042
Vancouver
Tanaka K, Seger L, Tieu K, Witcher K, Turan O, Turan S. Laterality Spectrum Disorders in the Prenatal Era: Outcomes Across the Severity Spectrum and Associations with Pregestational Diabetes. American Journal of Perinatology. 2026;43(08):1051-1058. doi:10.1055/a-2852-5042
BibTeX
@article{Tanaka2026,
author = {Tanaka, Kunio and Seger, Lindsey and Tieu, Kenneth and Witcher, Kristina and Turan, Ozhan and Turan, Sifa},
title = {Laterality Spectrum Disorders in the Prenatal Era: Outcomes Across the Severity Spectrum and Associations with Pregestational Diabetes},
journal = {American Journal of Perinatology},
year = {2026},
volume = {43},
number = {08},
pages = {1051--1058},
doi = {10.1055/a-2852-5042}
}
EUVIMED